CtNorm: Actual time PCR cycle of threshold (Ct) normalization algorithm
In relative quantification with Actual Time PCR (qRT-PCR,), correct evaluation requires equal amplification effectivity for each genes (Gene of curiosity and reference gene) and equal threshold values for all of the samples. On this quantification technique the expression stage in handled samples shall be calculated compared to the management group. We carried out the current examine to design an algorithm for changing the info obtained from totally different runs containing similar customary samples into one run with the identical amplification effectivity and threshold worth.
For this goal, two formulation have been designed; one to transform the amplification effectivity of the every run to 100%, and the opposite one for changing knowledge from totally different runs into one run. Using these two formulation, an algorithm was developed and named CtNorm. The web model of CtNorm algorithm is on the market at http://ctnorm.sums.ac.ir/. We used qRT-PCR method to validate the accuracy of the designed algorithm for the normalization of 4 totally different human inside management genes.
Normalizing the Ct values obtained from separate runs with the CtNorm algorithm has eradicated the variations and the common of the Ct values has change into much like the situation during which all of the samples have been amplified in a single run. The CtNorm algorithm could possibly be utilized for equalizing the Ct values of a number of qRT-PCR runs with the identical customary samples. The algorithm has additionally the flexibility to transform the amplification effectivity to 100% which is helpful in absolute and relative quantification.
Guinea Pig Uterus cDNA |
|||
| GD-411 | Zyagen | 30 reactions | EUR 243 |
Cat Uterus Total RNA* |
|||
| FR-411 | Zyagen | 0.05mg | EUR 195 |
Cat Uterus Genomic DNA |
|||
| FG-411 | Zyagen | 0.1mg | EUR 210 |
Cat Uterus Total Protein |
|||
| FT-411 | Zyagen | 1mg | EUR 176 |
cDNA - Human Tumor Tissue: Uterus |
|||
| C1235274 | Biochain | 40 reactions | EUR 467.25 |
Rat Uterus, non-pregnant cDNA |
|||
| RD-411 | Zyagen | 30 reactions | EUR 243 |
Mouse CD1 Uterus, non-pregnant cDNA |
|||
| MD-411 | Zyagen | 30 reactions | EUR 243 |
Mouse BLC Uterus, non-pregnant cDNA |
|||
| MD-411-BLC | Zyagen | 30 reactions | EUR 280 |
Mouse C57 Uterus, non-pregnant cDNA |
|||
| MD-411-C57 | Zyagen | 30 reactions | EUR 280 |
cDNA - Human Adult Normal Tissue: Uterus |
|||
| C1234274 | Biochain | 40 reactions | EUR 311.5 |
cDNA - Monkey (Rhesus) Normal Tissue: Uterus |
|||
| C1534274 | Biochain | 40 reactions | EUR 531.3 |
cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus |
|||
| C1534274-Cy | Biochain | 40 reactions | EUR 531.3 |
cDNA - Human Adult Normal Tissue: Uterus: Cervix |
|||
| C1234275 | Biochain | 40 reactions | EUR 311.5 |
cDNA - Human Adult Normal Tissue: Uterus: Corpus |
|||
| C1234276-10 | Biochain | 10 reactions | EUR 173.95 |
cDNA - Human Adult Normal Tissue: Uterus: Fundus |
|||
| C1234278-10 | Biochain | 10 reactions | EUR 173.95 |
cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Cervix |
|||
| C1534275 | Biochain | 40 reactions | EUR 531.3 |
cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Corpus |
|||
| C1534276 | Biochain | 40 reactions | EUR 531.3 |
cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Fundus |
|||
| C1534278 | Biochain | 40 reactions | EUR 531.3 |
Rat Uterus, non-pregnant cDNA-Random Primer |
|||
| RD-411-RH | Zyagen | 30 reactions | EUR 243 |
cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus: Cervix |
|||
| C1534275-Cy | Biochain | 40 reactions | EUR 531.3 |
Rat WS Uterus, non-pregnant cDNA-Oligo-dT |
|||
| RD-411-WS | Zyagen | 30 reactions | EUR 243 |
Mouse C57 Uterus, non-pregnant cDNA-Random Primer |
|||
| MD-411-C57-RH | Zyagen | 30 reactions | EUR 280 |
Mouse CD1 Uterus, non-pregnant cDNA-Random Primer |
|||
| MD-411-HR | Zyagen | 30 reactions | EUR 243 |
Tissue cDNA, First Strand, Human Tumor, Uterus, BioGenomics |
|||
| MBS651979-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Human Tumor, Uterus, BioGenomics |
|||
| MBS651979-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, BioGenomics |
|||
| MBS651999-40Tests | MyBiosource | 40Tests | EUR 680 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, BioGenomics |
|||
| MBS651999-5x40Tests | MyBiosource | 5x40Tests | EUR 2835 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Cervix, BioGenomics |
|||
| MBS651890-40Tests | MyBiosource | 40Tests | EUR 680 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Cervix, BioGenomics |
|||
| MBS651890-5x40Tests | MyBiosource | 5x40Tests | EUR 2835 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, BioGenomics |
|||
| MBS652015-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, BioGenomics |
|||
| MBS652015-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Corpus, BioGenomics |
|||
| MBS652435-10Tests | MyBiosource | 10Tests | EUR 540 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Corpus, BioGenomics |
|||
| MBS652435-5x10Tests | MyBiosource | 5x10Tests | EUR 2215 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Fundus, BioGenomics |
|||
| MBS652490-10Tests | MyBiosource | 10Tests | EUR 540 |
Tissue cDNA, First Strand, Human Adult Normal, Uterus, Fundus, BioGenomics |
|||
| MBS652490-5x10Tests | MyBiosource | 5x10Tests | EUR 2215 |
Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, BioGenomics |
|||
| MBS652498-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, BioGenomics |
|||
| MBS652498-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Fundus, BioGenomics |
|||
| MBS652111-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Fundus, BioGenomics |
|||
| MBS652111-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Corpus, BioGenomics |
|||
| MBS652277-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Corpus, BioGenomics |
|||
| MBS652277-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Cervix, BioGenomics |
|||
| MBS652482-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Cervix, BioGenomics |
|||
| MBS652482-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, Cervis, BioGenomics |
|||
| MBS651910-40Tests | MyBiosource | 40Tests | EUR 850 |
Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, Cervis, BioGenomics |
|||
| MBS651910-5x40Tests | MyBiosource | 5x40Tests | EUR 3600 |
Uterus Lysate |
|||
| MBS151639-01mg | MyBiosource | 0.1mg | EUR 200 |
Uterus Lysate |
|||
| MBS151639-5x01mg | MyBiosource | 5x0.1mg | EUR 880 |
Uterus, Rabbit |
|||
| MBS639336-25Each | MyBiosource | 25Each | EUR 395 |
Uterus, Rabbit |
|||
| MBS639336-5x25Each | MyBiosource | 5x25Each | EUR 1550 |
Uterus, Bovine |
|||
| MBS639365-5Each | MyBiosource | 5Each | EUR 395 |
Uterus, Bovine |
|||
| MBS639365-5x5Each | MyBiosource | 5x5Each | EUR 1550 |
Dog Uterus RNA* |
|||
| DR-411 | Zyagen | 0.05mg | EUR 195 |
BOVINE, UTERUS, FRESH |
|||
| 8600861 | Lampire Biologicals Laboratories | 1EA | EUR 67.09 |
Uterus Tumor Lysate |
|||
| MBS151717-01mg | MyBiosource | 0.1mg | EUR 260 |
Uterus Tumor Lysate |
|||
| MBS151717-5x01mg | MyBiosource | 5x0.1mg | EUR 1140 |
Fetal Uterus Lysate |
|||
| XBL-10431 | ProSci | 0.1 mg | EUR 632.4 |
|
Description: Fetal human uterus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human uterus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the uterus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The uterus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
PORCINE, UTERUS, FRESH |
|||
| 8604961 | Lampire Biologicals Laboratories | 1EA | EUR 65.63 |
BOVINE, UTERUS, FROZEN |
|||
| 8620861 | Lampire Biologicals Laboratories | 1EA | EUR 67.09 |
PORCINE, UTERUS, FROZEN |
|||
| 8624961 | Lampire Biologicals Laboratories | 1EA | EUR 65.63 |
Rat Uterus Fibroblasts |
|||
| ABC-TC4237 | AcceGen | 1 vial | Ask for price |
|
Description: Rat uterus fibroblasts, 6-week Wistar rat |
|||
OORA00351-10U - UTERUS |
|||
| OORA00351-10U | Aviva Systems Biology | 1Each | EUR 105 |
OORA00351-1EA - UTERUS |
|||
| OORA00351-1EA | Aviva Systems Biology | 1Each | EUR 99 |
OORA00493-10U - UTERUS |
|||
| OORA00493-10U | Aviva Systems Biology | 1Each | EUR 55 |
OORA00493-1EA - UTERUS |
|||
| OORA00493-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Uterus Membrane Lysate |
|||
| XBL-11023 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Tissue, Total RNA, Human Adult Normal, Uterus, Corpus of Uterus, BioGenomics |
|||
| MBS638682-001mg | MyBiosource | 0.01mg | EUR 485 |
Tissue, Total RNA, Human Adult Normal, Uterus, Corpus of Uterus, BioGenomics |
|||
| MBS638682-5x001mg | MyBiosource | 5x0.01mg | EUR 1960 |
Tissue, Total RNA, Human Adult Normal, Uterus, Cervix of uterus, BioGenomics |
|||
| MBS638538-005mg | MyBiosource | 0.05mg | EUR 495 |
Tissue, Total RNA, Human Adult Normal, Uterus, Cervix of uterus, BioGenomics |
|||
| MBS638538-5x005mg | MyBiosource | 5x0.05mg | EUR 1995 |
Pig Uterus Total RNA |
|||
| PR-411 | Zyagen | 0.1mg | EUR 235 |
Dog Uterus Genomic DNA |
|||
| DG-411 | Zyagen | 0.1mg | EUR 210 |
Pig Uterus Genomic DNA |
|||
| PG-411 | Zyagen | 0.1mg | EUR 177 |
Rat Uterus Genomic DNA |
|||
| RG-411 | Zyagen | 0.1mg | EUR 177 |
Sheep Uterus Total RNA |
|||
| SR-411 | Zyagen | 0.1mg | EUR 160 |
Bovine Uterus Total RNA |
|||
| BR-411 | Zyagen | 0.1mg | EUR 160 |
Rabbit Uterus Total RNA |
|||
| TR-411 | Zyagen | 0.1mg | EUR 160 |
Dog Uterus Total Protein |
|||
| DT-411 | Zyagen | 1mg | EUR 176 |
Hamster Uterus Total RNA* |
|||
| AR-411 | Zyagen | 0.05mg | EUR 160 |
Human Uterus Genomic DNA |
|||
| HG-411 | Zyagen | 0.05mg | EUR 210 |
Mouse Uterus Genomic DNA |
|||
| MG-411 | Zyagen | 0.1mg | EUR 177 |
MiniPig Uterus Total RNA |
|||
| NR-411 | Zyagen | 0.1mg | EUR 231 |
Pig Uterus Total Protein |
|||
| PT-411 | Zyagen | 1mg | EUR 153 |
Sheep Uterus Genomic DNA |
|||
| SG-411 | Zyagen | 0.1mg | EUR 177 |
Bovine Uterus Genomic DNA |
|||
| BG-411 | Zyagen | 0.1mg | EUR 177 |
Human Uterus Tumor lysate |
|||
| HTL-1384 | Alpha Diagnostics | 1 mg | EUR 927.6 |
Equine Uterus Genomic DNA |
|||
| GE-411 | Zyagen | 0.1mg | EUR 210 |
OORA00552-1U - Rat UTERUS |
|||
| OORA00552-1U | Aviva Systems Biology | 1Each | EUR 60 |
Rabbit Uterus Genomic DNA |
|||
| TG-411 | Zyagen | 0.1mg | EUR 177 |
Uterus tumor tissue array |
|||
| UT802a | TissueArray | each | EUR 306 |
|
Description: Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802 |
|||
Uterus Tissue Slide (Normal) |
|||
| 11-401-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Normal) |
|||
| 11-401-4um | ProSci | 4 um | EUR 216.6 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-4um | ProSci | 4 um | EUR 216.6 |
Chicken Uterus Genomic DNA |
|||
| GC-411 | Zyagen | 0.1mg | EUR 177 |
Hamster Uterus Genomic DNA |
|||
| GA-411 | Zyagen | 0.1mg | EUR 177 |
Human Uterus Tissue Lysate |
|||
| IHUUTETL100UG | Innovative research | each | EUR 245 |
|
Description: Human Uterus Tissue Lysate |
|||
Uterus Tissue Slide (Benign) |
|||
| MBS154229-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Benign) |
|||
| MBS154229-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Benign) |
|||
| MBS154229-5x10um | MyBiosource | 5x10um | EUR 920 |
Uterus Tissue Slide (Normal) |
|||
| MBS154314-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Normal) |
|||
| MBS154314-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Normal) |
|||
| MBS154314-5x10um | MyBiosource | 5x10um | EUR 920 |
Human Uterus Tissue Lysate |
|||
| MBS8420151-01mg | MyBiosource | 0.1mg | EUR 385 |
Human Uterus Tissue Lysate |
|||
| MBS8420151-5x01mg | MyBiosource | 5x0.1mg | EUR 1540 |
OORA00552-1EA - Rat UTERUS |
|||
| OORA00552-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Pig Uterus Frozen Sections |
|||
| PF-411 | Zyagen | 10 slides | EUR 261 |
Sheep Uterus Total Protein |
|||
| ST-411 | Zyagen | 1mg | EUR 153 |
Total-RNA---Lupus:-Uterus |
|||
| R1236274Lup-50 | Biochain | 50 ug | EUR 338.1 |
Bovine Uterus Total Protein |
|||
| BT-411 | Zyagen | 1mg | EUR 153 |
Rabbit Uterus Total Protein |
|||
| TT-411 | Zyagen | 1mg | EUR 153 |
57153-2 BV UTERUS 5 EA* |
|||
| 57153-2 | Pel-Freez | 5 EA | EUR 300 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-4um | ProSci | 4 um | EUR 216.6 |
Hamster Uterus Total Protein |
|||
| AT-411 | Zyagen | 1mg | EUR 153 |
Chicken Uterus Total Protein |
|||
| CT-411 | Zyagen | 1mg | EUR 140 |
Uterus Tissue Slide (Abnormal) |
|||
| MBS154337-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Abnormal) |
|||
| MBS154337-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Abnormal) |
|||
| MBS154337-5x10um | MyBiosource | 5x10um | EUR 920 |
MiniPig Uterus Total Protein |
|||
| NT-411 | Zyagen | 1mg | EUR 176 |
OORA00523-1U - Rabbit UTERUS |
|||
| OORA00523-1U | Aviva Systems Biology | 1Each | EUR 255 |
Pig Uterus Paraffin Sections |
|||
| PP-411 | Zyagen | 10 slides | EUR 240 |
Sheep Uterus Frozen Sections |
|||
| SF-411 | Zyagen | 10 slides | EUR 261 |
Uterus Membrane Tumor Lysate |
|||
| XBL-11031 | ProSci | 0.1 mg | EUR 752.1 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Bovine Uterus Frozen Sections |
|||
| BF-411 | Zyagen | 10 slides | EUR 261 |
Equine Uterus Frozen Sections |
|||
| EF-411 | Zyagen | 10 slides | EUR 261 |
OORA00523-1EA - Rabbit UTERUS |
|||
| OORA00523-1EA | Aviva Systems Biology | 1Each | EUR 239 |
Rabbit Uterus Frozen Sections |
|||
| TF-411 | Zyagen | 10 slides | EUR 240 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-4um | ProSci | 4 um | EUR 216.6 |
Hamster Uterus Frozen Sections |
|||
| AF-411 | Zyagen | 10 slides | EUR 240 |
Human Uterus Paraffin Sections |
|||
| HP-411 | Zyagen | 10 slides | EUR 319 |
Uterus Tissue Slide (Adenomyoma) |
|||
| MBS154292-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Adenomyoma) |
|||
| MBS154292-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Adenomyoma) |
|||
| MBS154292-5x10um | MyBiosource | 5x10um | EUR 920 |
MiniPig Uterus Frozen Sections |
|||
| NF-411 | Zyagen | 10 slides | EUR 307 |
OORA00470-10U - Hamster UTERUS |
|||
| OORA00470-10U | Aviva Systems Biology | 1Each | EUR 75 |
OORA00470-1EA - Hamster UTERUS |
|||
| OORA00470-1EA | Aviva Systems Biology | 1Each | EUR 69 |
Sheep Uterus Paraffin Sections |
|||
| SP-411 | Zyagen | 10 slides | EUR 240 |
Bovine Uterus Paraffin Sections |
|||
| BP-411 | Zyagen | 10 slides | EUR 240 |
Equine Uterus Paraffin Sections |
|||
| EP-411 | Zyagen | 10 slides | EUR 240 |
OCPB00133-100UG - Uterus Lysate |
|||
| OCPB00133-100UG | Aviva Systems Biology | 0.1mg | EUR 139 |
Uterus-Corpus Membrane Lysate |
|||
| XBL-11037 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus-corpus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-corpus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-corpus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-corpus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Uterus-Fundus Membrane Lysate |
|||
| XBL-11040 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus-fundus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-fundus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-fundus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-fundus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Rat Uterus-E12 Total RNA |
|||
| RR-411-12 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E13 Total RNA |
|||
| RR-411-13 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E14 Total RNA |
|||
| RR-411-14 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E15 Total RNA |
|||
| RR-411-15 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E16 Total RNA |
|||
| RR-411-16 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E17 Total RNA |
|||
| RR-411-17 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E18 Total RNA |
|||
| RR-411-18 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E19 Total RNA |
|||
| RR-411-19 | Zyagen | 0.05mg | EUR 160 |
Rat Uterus-E20 Total RNA |
|||
| RR-411-20 | Zyagen | 0.05mg | EUR 160 |
Hamster Uterus Paraffin Sections |
|||
| AP-411 | Zyagen | 10 slides | EUR 228 |
MiniPig Uterus Paraffin Sections |
|||
| NP-411 | Zyagen | 10 slides | EUR 307 |
Guinea Pig Uterus Total RNA |
|||
| GR-411 | Zyagen | 0.1mg | EUR 160 |
Mini Pig Uterus Genomic DNA |
|||
| GN-411 | Zyagen | 0.1mg | EUR 210 |
Mouse C57 Uterus Genomic DNA |
|||
| MG-411-C57 | Zyagen | 0.05mg | EUR 210 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-4um | ProSci | 4 um | EUR 216.6 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| MBS154197-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| MBS154197-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| MBS154197-5x10um | MyBiosource | 5x10um | EUR 920 |
41253-2 RB UTERUS Y 25 EA* |
|||
| 41253-2 | Pel-Freez | 25 EA | EUR 263 |
Guinea Pig Uterus Genomic DNA |
|||
| GG-411 | Zyagen | 0.1mg | EUR 177 |
Guinea Pig Uterus Total Protein |
|||
| GT-411 | Zyagen | 0.5mg | EUR 153 |
Uterus cancer test tissue array |
|||
| T093 | TissueArray | each | EUR 78 |
|
Description: Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores |
|||
Human Uterus Fetal Tissue Lysate |
|||
| IHUUTEFSTL100UG | Innovative research | each | EUR 1133 |
|
Description: Human Uterus Fetal Tissue Lysate |
|||
Human Uterus Tumor Tissue Lysate |
|||
| IHUUTETLT100UG | Innovative research | each | EUR 361 |
|
Description: Human Uterus Tumor Tissue Lysate |
|||
Human Uterus Fetal Tissue Lysate |
|||
| MBS8420150-01mg | MyBiosource | 0.1mg | EUR 1465 |
Human Uterus Fetal Tissue Lysate |
|||
| MBS8420150-5x01mg | MyBiosource | 5x0.1mg | EUR 6415 |
Human Uterus Tumor Tissue Lysate |
|||
| MBS8420153-01mg | MyBiosource | 0.1mg | EUR 525 |
Human Uterus Tumor Tissue Lysate |
|||
| MBS8420153-5x01mg | MyBiosource | 5x0.1mg | EUR 2180 |
Leiomyoma of uterus tissue array |
|||
| SO806 | TissueArray | each | EUR 270 |
|
Description: Leiomyoma of uterus tissue array, 80 cases/80 cores |
|||
Monkey Rhesus Uterus Genomic DNA |
|||
| UG-411 | Zyagen | 0.1mg | EUR 210 |
Guinea Pig Uterus Frozen Sections |
|||
| GF-411 | Zyagen | 10 slides | EUR 240 |
OORA00440-10U - GUINEA PIG UTERUS |
|||
| OORA00440-10U | Aviva Systems Biology | 1Each | EUR 80 |
OORA00440-1EA - GUINEA PIG UTERUS |
|||
| OORA00440-1EA | Aviva Systems Biology | 1Each | EUR 79 |
Guinea Pig Uterus Paraffin Sections |
|||
| GP-411 | Zyagen | 10 slides | EUR 228 |
Monkey Cynomolgus Uterus Genomic DNA |
|||
| KG-411 | Zyagen | 0.1mg | EUR 210 |
Human Uterus Lysate Membrane Fraction |
|||
| IHUUTETLM100UG | Innovative research | each | EUR 870 |
|
Description: Human Uterus Lysate Membrane Fraction |
|||
OCPB00088-100UG - Uterus Tumor Lysate |
|||
| OCPB00088-100UG | Aviva Systems Biology | 0.1mg | EUR 199 |
OCPB00611-100UG - Fetal Uterus Lysate |
|||
| OCPB00611-100UG | Aviva Systems Biology | 0.1mg | EUR 579 |
Human Uterus Lysate Membrane Fraction |
|||
| MBS8420152-01mg | MyBiosource | 0.1mg | EUR 1145 |
Human Uterus Lysate Membrane Fraction |
|||
| MBS8420152-5x01mg | MyBiosource | 5x0.1mg | EUR 4960 |
Rat Uterus, non-pregnant Total RNA |
|||
| RR-411 | Zyagen | 0.1mg | EUR 160 |
OCPB00744-100UG - Uterus Membrane Lysate |
|||
| OCPB00744-100UG | Aviva Systems Biology | 0.1mg | EUR 559 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-4um | ProSci | 4 um | EUR 216.6 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| MBS154209-10um | MyBiosource | 10um | EUR 210 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| MBS154209-4um | MyBiosource | 4um | EUR 195 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| MBS154209-5x10um | MyBiosource | 5x10um | EUR 920 |
Tissue, Total Protein, Human Tumor, Uterus |
|||
| MBS657307-1mg | MyBiosource | 1mg | EUR 680 |
Tissue, Total Protein, Human Tumor, Uterus |
|||
| MBS657307-5x1mg | MyBiosource | 5x1mg | EUR 2835 |
Rat Uterus, non-pregnant Total Protein |
|||
| RT-411 | Zyagen | 0.5mg | EUR 153 |
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEF | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEP | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTES | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEZ | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Enchancment of pneumococcal pneumonia prognosis utilizing quantitative real-time PCR concentrating on lytA in grownup sufferers: A potential cohort examine
Aims: The intention of the examine was to evaluate the efficiency of real-time polymerase chain response (PCR) concentrating on the lytA gene (rtPCR-lytA) in plasma, urine and nasopharyngeal (NP) samples for the prognosis of pneumococcal community-acquired pneumonia (P-CAP).
Strategies: Potential observational examine together with all consecutive grownup CAP sufferers from November 2015 to Could 2017. P-CAP was outlined if pneumococcus was recognized utilizing typical strategies (CM) and/or a optimistic rtPCR-lytA was detected in blood, urine or NP samples (NP cut-off ≥8000 copies/mL). Diagnostic efficiency of every check was calculated.
Outcomes: 133 CAP sufferers have been included. Of those, P-CAP was identified in 62 circumstances (46.6%). The proportion of P-CAP identified by rtPCR-lytA strategies was considerably larger than by CM (87.1% vs 59.7%, p=0.005). RtPCR-lytA recognized S. pneumoniae in 25 sufferers (40.3% of all P-CAP circumstances) whose prognosis would have been missed by CM. NP-rtPCR-lytA allowed diagnosing 62.3% of P-CAP. A nasopharyngeal colonisation density ≥2351 copies/mL predicted P-CAP prognosis (AUC=0.82, sensitivity=83.3%, specificity=80.9%). There was a optimistic correlation between growing bacterial load in blood and CURB65 (Spearman correlation coefficient r=0.4, p=0.001), PSI (r=0.3, p=0.02), and time to scientific stability (r=0.33, p=0.01). Median bacterial load in blood was larger in P-CAP sufferers with bacteraemia (0.65×103 vs 0x103 copies/mL, p=0.002), ICU admission (0.68×103 vs 0x103 copies/mL, p=0.04) or mechanical air flow (7.45×103 vs 0x103 copies/mL, p=0.04).
Conclusions: The usage of rtPCR-lytA strategies considerably elevated the prognosis of P-CAP as in comparison with CM. Nasopharyngeal swabs rtPCR-lytA detection, with an correct cut-off worth, was essentially the most promising amongst molecular strategies for the prognosis of P-CAP.
Epidemiology and scientific options of intestinal protozoan infections detected by Actual-Time PCR in non-native kids inside an Italian tertiary care kids’s hospital: a cross-sectional examine
Background: Enteric parasite infections are underestimated because of the restricted sensitivity and specificity of microscopy, which stays the diagnostic gold customary in routine scientific apply. This could possibly be a serious drawback in high-income nations, the place the burden of parasitic illnesses is low. Lately, Multiplex Actual-Time polymerase chain response (RT-PCR) primarily based strategies have been applied. Due to this fact, the intention of this examine was to judge the prevalence of 4 enteric protozoan species detected by RT-PCR in non-native kids in Italy, and to explain their scientific traits.
Strategies: Adopted and immigrant kids, evaluated for migration well being evaluation between 2017 and 2020 in a tertiary care kids’s hospital in Italy, have been enrolled. Molecular evaluation for Giardia lamblia, Dientamoeba fragilis, Blastocystis hominis, and Entamoeba histolytica, was carried out by in-house RT-PCR.
Outcomes: Total, 209 kids have been enrolled and 70% of them resulted optimistic by RT-PCR for no less than one enteric parasite. B. hominis (47.8%) was essentially the most generally recognized protozoa, adopted by D. fragilis (44.5%). Co-infections with a number of pathogens have been detected in 35.4% of the samples. Nearly 80% of parasite-positive kids have been asymptomatic and the most typical symptom was flatulence (60.7% of symptomatic kids). Eosinophils have been considerably elevated in RT-PCR optimistic kids in comparison with the detrimental ones and youngsters with D. fragilis offered the very best eosinophils rely.
Conclusions: The In-house Multiplex RT-PCR assay gives a sound molecular detection system for chosen enteric parasites. This novel and correct diagnostic technique might help in growing the detection price of parasite an infection, particularly in high-risk inhabitants.
Novel common primer-pentaplex PCR assay primarily based on chimeric primers for simultaneous detection of 5 widespread pig viruses related to diarrhea
Viral pathogens related to diarrhea in pigs embody porcine circovirus 2 (PCV2), porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), porcine rotavirus A (RVA) and C (RVC) amongst others. On this examine, a novel common primer-based pentaplex PCR (UP-M-PCR) assay was developed for simultaneous detection and differentiation of those 5 viruses.
The assay makes use of a short-cycle multiplex amplification by chimeric primers (CP), that are virus particular, with a tail added on the 5′ finish of the common primer (UP), adopted by common amplification utilizing UPs and a common cycle amplification. 5 common primers with CPs (UP1-5) have been designed and evaluated in an UP-based single PCR (UP-S-PCR). All 5 UPs have been discovered to work effectively and UP2 exhibited the most effective efficiency.
After system optimizations, the analytical sensitivity of the UP-M-PCR, utilizing plasmids containing the particular viral goal fragments, was 5 copies/response for every of the 5 viruses regardless of presence of a single or a number of viruses within the template. No cross-reaction was noticed with different non-target viruses. When 273 fecal samples from clinically wholesome pigs have been examined, the assay sensitivity was 90.9-100%, the specificity was 98.0-100%, and the settlement price with the UP-S-PCR was 98.5-99.6% with a Kappa worth being 0.95-0.98. In abstract, the UP-M-PCR developed here’s a fast and extremely delicate and particular detection technique that can be utilized to reveal combined infections in pigs with diarrhea.
SLC52A1 Antibody |
|||
| 1-CSB-PA030173 | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/10000 |
|||
SLC52A1 Antibody |
|||
| 1-CSB-PA977414 | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
SLC52A1 Antibody |
|||
| E037605 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
SLC52A1 Antibody |
|||
| E40PV7682 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
SLC52A1 Antibody |
|||
| MBS7000748-005mg | MyBiosource | 0.05mg | EUR 190 |
SLC52A1 Antibody |
|||
| MBS7000748-01mg | MyBiosource | 0.1mg | EUR 270 |
SLC52A1 Antibody |
|||
| MBS7000748-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
SLC52A1 Antibody |
|||
| MBS7129016-005mL | MyBiosource | 0.05mL | EUR 190 |
SLC52A1 Antibody |
|||
| MBS7129016-01mL | MyBiosource | 0.1mL | EUR 270 |
SLC52A1 Antibody |
|||
| MBS7129016-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
SLC52A1 Antibody |
|||
| MBS7129017-005mL | MyBiosource | 0.05mL | EUR 190 |
SLC52A1 Antibody |
|||
| MBS7129017-01mL | MyBiosource | 0.1mL | EUR 270 |
SLC52A1 Antibody |
|||
| MBS7129017-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
SLC52A1 Antibody |
|||
| MBS7118522-005mg | MyBiosource | 0.05mg | EUR 150 |
SLC52A1 Antibody |
|||
| MBS7118522-01mg | MyBiosource | 0.1mg | EUR 190 |
SLC52A1 Antibody |
|||
| MBS7118522-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
SLC52A1 Antibody |
|||
| MBS9404758-01mL | MyBiosource | 0.1mL | EUR 305 |
SLC52A1 Antibody |
|||
| MBS9404758-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
SLC52A1 Antibody (HRP) |
|||
| abx311449-100g | Abbexa | 100 µg | EUR 362.5 |
SLC52A1 Antibody (HRP) |
|||
| 20-abx311449 | Abbexa |
|
|
SLC52A1 Antibody (HRP) |
|||
| abx311449-20g | Abbexa | 20 µg | EUR 162.5 |
SLC52A1 Antibody (HRP) |
|||
| abx311449-50g | Abbexa | 50 µg | EUR 250 |
SLC52A1 Antibody (FITC) |
|||
| abx311450-100g | Abbexa | 100 µg | EUR 362.5 |
SLC52A1 Antibody (FITC) |
|||
| 20-abx311450 | Abbexa |
|
|
SLC52A1 Antibody (FITC) |
|||
| abx311450-20g | Abbexa | 20 µg | EUR 162.5 |
SLC52A1 Antibody (FITC) |
|||
| abx311450-50g | Abbexa | 50 µg | EUR 250 |
SLC52A1 Antibody (Biotin) |
|||
| abx311451-100g | Abbexa | 100 µg | EUR 362.5 |
SLC52A1 Antibody (Biotin) |
|||
| 20-abx311451 | Abbexa |
|
|
SLC52A1 Antibody (Biotin) |
|||
| abx311451-20g | Abbexa | 20 µg | EUR 162.5 |
SLC52A1 Antibody (Biotin) |
|||
| abx311451-50g | Abbexa | 50 µg | EUR 250 |
SLC52A1 Polyclonal Antibody |
|||
| A67622 | EpiGentek |
|
|
SLC52A1 Conjugated Antibody |
|||
| C37605 | SAB | 100ul | EUR 476.4 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2524717-002mL | MyBiosource | 0.02mL | EUR 135 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2524717-006mL | MyBiosource | 0.06mL | EUR 190 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2524717-012mL | MyBiosource | 0.12mL | EUR 265 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2524717-02mL | MyBiosource | 0.2mL | EUR 415 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2524717-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2519013-002mL | MyBiosource | 0.02mL | EUR 135 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2519013-006mL | MyBiosource | 0.06mL | EUR 190 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2519013-012mL | MyBiosource | 0.12mL | EUR 265 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2519013-02mL | MyBiosource | 0.2mL | EUR 415 |
SLC52A1 Polyclonal Antibody |
|||
| MBS2519013-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
SLC52A1 Conjugated Antibody |
|||
| MBS9448044-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
SLC52A1 Conjugated Antibody |
|||
| MBS9448044-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
SLC52A1 Conjugated Antibody |
|||
| MBS9448044-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
SLC52A1 Conjugated Antibody |
|||
| MBS9448044-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
SLC52A1 Conjugated Antibody |
|||
| MBS9448044-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
SLC52A1 Antibody, HRP conjugated |
|||
| 1-CSB-PA878904LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
SLC52A1 Antibody; HRP conjugated |
|||
| MBS7005036-005mg | MyBiosource | 0.05mg | EUR 190 |
SLC52A1 Antibody; HRP conjugated |
|||
| MBS7005036-01mg | MyBiosource | 0.1mg | EUR 270 |
SLC52A1 Antibody; HRP conjugated |
|||
| MBS7005036-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
SLC52A1 Antibody, FITC conjugated |
|||
| 1-CSB-PA878904LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
SLC52A1 Antibody; FITC conjugated |
|||
| MBS7000492-005mg | MyBiosource | 0.05mg | EUR 190 |
SLC52A1 Antibody; FITC conjugated |
|||
| MBS7000492-01mg | MyBiosource | 0.1mg | EUR 270 |
SLC52A1 Antibody; FITC conjugated |
|||
| MBS7000492-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OACA06221-50UG - SLC52A1 Antibody |
|||
| OACA06221-50UG | Aviva Systems Biology | 50ug | EUR 179 |
SLC52A1 Antibody, Biotin conjugated |
|||
| 1-CSB-PA878904LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
SLC52A1 Antibody; Biotin conjugated |
|||
| MBS7003593-005mg | MyBiosource | 0.05mg | EUR 190 |
SLC52A1 Antibody; Biotin conjugated |
|||
| MBS7003593-01mg | MyBiosource | 0.1mg | EUR 270 |
SLC52A1 Antibody; Biotin conjugated |
|||
| MBS7003593-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OAAF05202-100UG - SLC52A1 Antibody |
|||
| OAAF05202-100UG | Aviva Systems Biology | 100ug | EUR 329 |
OAAJ06024-100UL - SLC52A1 Antibody |
|||
| OAAJ06024-100UL | Aviva Systems Biology | 100uL | EUR 319 |
OACA06221-100UG - SLC52A1 Antibody |
|||
| OACA06221-100UG | Aviva Systems Biology | 100ug | EUR 319 |
SLC52A1 Rabbit Polyclonal Antibody |
|||
| E10G04915 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
SLC52A1 Rabbit Polyclonal Antibody |
|||
| E10G11802 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
SLC52A1 Polyclonal Antibody, HRP Conjugated |
|||
| A67623 | EpiGentek |
|
|
SLC52A1 Polyclonal Antibody, FITC Conjugated |
|||
| A67624 | EpiGentek |
|
|
SLC52A1 Polyclonal Antibody, Biotin Conjugated |
|||
| A67625 | EpiGentek |
|
|
OASG03143-100UL - SLC52A1 Antibody - middle region |
|||
| OASG03143-100UL | Aviva Systems Biology | 100ul | EUR 239 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx324146-100g | Abbexa | 100 µg | EUR 250 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx324146 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx324146-50g | Abbexa | 50 µg | EUR 187.5 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx211053-100l | Abbexa | 100 µl | EUR 350 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx211053 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx211053-50l | Abbexa | 50 µl | EUR 250 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx211054-100l | Abbexa | 100 µl | EUR 350 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx211054 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx211054-50l | Abbexa | 50 µl | EUR 250 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx302068-100g | Abbexa | 100 µg | EUR 362.5 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx302068 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx302068-20g | Abbexa | 20 µg | EUR 162.5 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| abx302068-50g | Abbexa | 50 µg | EUR 250 |
Human SLC52A1 siRNA |
|||
| 20-abx934068 | Abbexa |
|
|
SLC52A1 siRNA (Human) |
|||
| MBS8240786-15nmol | MyBiosource | 15nmol | EUR 405 |
SLC52A1 siRNA (Human) |
|||
| MBS8240786-30nmol | MyBiosource | 30nmol | EUR 565 |
SLC52A1 siRNA (Human) |
|||
| MBS8240786-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
Human SLC52A1 shRNA Plasmid |
|||
| 20-abx960440 | Abbexa |
|
|
Human SLC52A1 Protein Lysate |
|||
| MBS8419731-002mg | MyBiosource | 0.02mg | EUR 365 |
Human SLC52A1 Protein Lysate |
|||
| MBS8419731-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
SLC52A1 Recombinant Protein (Human) |
|||
| RP097485 | ABM | 100 ug | Ask for price |
SLC52A1 ORF Vector (Human) (pORF) |
|||
| ORF032496 | ABM | 1.0 ug DNA | Ask for price |
anti- SLC16A12 antibody |
|||
| FNab07910 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC16A12 |
|||
anti- SLC22A15 antibody |
|||
| FNab07920 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC22A15 |
|||
anti- SLC22A18 antibody |
|||
| FNab07921 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A18 |
|||
anti- SLC22A23 antibody |
|||
| FNab07924 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A23 |
|||
anti- SLC25A10 antibody |
|||
| FNab07928 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A10 |
|||
anti- SLC25A11 antibody |
|||
| FNab07929 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC25A11 |
|||
anti- SLC25A13 antibody |
|||
| FNab07930 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A13 |
|||
anti- SLC25A15 antibody |
|||
| FNab07931 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A15 |
|||
anti- SLC25A18 antibody |
|||
| FNab07932 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A18 |
|||
anti- SLC25A20 antibody |
|||
| FNab07934 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A20 |
|||
anti- SLC25A22 antibody |
|||
| FNab07935 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A22 |
|||
anti- SLC25A23 antibody |
|||
| FNab07936 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A23 |
|||
anti- SLC25A24 antibody |
|||
| FNab07937 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A24 |
|||
anti- SLC25A25 antibody |
|||
| FNab07938 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A25 |
|||
anti- SLC25A33 antibody |
|||
| FNab07940 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC25A33 |
|||
anti- SLC25A34 antibody |
|||
| FNab07941 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A34 |
|||
anti- SLC25A45 antibody |
|||
| FNab07943 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A45 |
|||
anti- SLC25A46 antibody |
|||
| FNab07944 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A46 |
|||
Human SLC52A1 knockout cell line |
|||
| ABC-KH14151 | AcceGen | 1 vial | Ask for price |
|
Description: Human SLC52A1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human SLC52A1 knockdown cell line |
|||
| ABC-KD14151 | AcceGen | 1 vial | Ask for price |
|
Description: Human SLC52A1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human SLC52A1 Protein Lysate 20ug |
|||
| IHUSLC52A1PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human SLC52A1 Protein Lysate 20ug |
|||
anti- SLC10A3 antibody |
|||
| FNab07904 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC10A3 |
|||
anti- SLC11A2 antibody |
|||
| FNab07905 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC11A2 |
|||
anti- SLC12A2 antibody |
|||
| FNab07906 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC12A2 |
|||
anti- SLC12A4 antibody |
|||
| FNab07907 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC12A4 |
|||
anti- SLC13A4 antibody |
|||
| FNab07909 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC13A4 |
|||
anti- SLC16A2 antibody |
|||
| FNab07911 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC16A2 |
|||
anti- SLC16A3 antibody |
|||
| FNab07912 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC16A3 |
|||
anti- SLC17A5 antibody |
|||
| FNab07913 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC17A5 |
|||
anti- SLC18A1 antibody |
|||
| FNab07914 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC18A1 |
|||
anti- SLC19A3 antibody |
|||
| FNab07915 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC19A3 |
|||
anti- SLC20A1 antibody |
|||
| FNab07917 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC20A1 |
|||
anti- SLC20A2 antibody |
|||
| FNab07918 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC20A2 |
|||
anti- SLC22A1 antibody |
|||
| FNab07919 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A1 |
|||
anti- SLC22A2 antibody |
|||
| FNab07923 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A2 |
|||
anti- SLC24A4 antibody |
|||
| FNab07925 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC24A4 |
|||
anti- SLC24A6 antibody |
|||
| FNab07926 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC24A6 |
|||
anti- SLC25A1 antibody |
|||
| FNab07927 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A1 |
|||
anti- SLC25A2 antibody |
|||
| FNab07933 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A2 |
|||
anti- SLC25A3 antibody |
|||
| FNab07939 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A3 |
|||
anti- SLC25A4 antibody |
|||
| FNab07942 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A4 |
|||